Natalia A Muraleva

6PUBLICATIONS
6CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)AutoimmunityVision scienceMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Empagliflozin, Linagliptin, and Metformin Differentially Affect Renal PI3K/Akt and MAPK/ERK Signaling Pathways in db/db Diabetic Mice.

|Jun 26, 2026
Features of Alteration in MAPK Pathway Activity in the Postnatal Brain of a Rat Model of Sporadic Alzheimer's Disease.

|Jun 25, 2025
Alterations of JNK Signaling Pathway Activity in the Rat Retina: Effects of Age, Age-Related Macular Degeneration-like Pathology, and a JNK Inhibitor (IQ-1S).

Natalia A Muraleva, Dmitry I Tikhonov, Anna A Zhdankina

|Jul 29, 2023
P38 MAPK Signaling in the Retina: Effects of Aging and Age-Related Macular Degeneration.

Natalia A Muraleva, Nataliya G Kolosova

|Jul 02, 2021
MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer's Disease: A Study in Senescence-Accelerated OXYS Rats.

Natalia A Muraleva, Nataliya G Kolosova, Natalia A Stefanova

|Aug 01, 2020
SkQ1 Suppresses the p38 MAPK Signaling Pathway Involved in Alzheimer's Disease-Like Pathology in OXYS Rats.

Natalia A Muraleva, Natalia A Stefanova, Nataliya G Kolosova

Pageof 1

Frequent Collaborators

5 joint publications

Nataliya G Kolosova

1 joint publications

Anna A Zhdankina

1 joint publications

Mark B Plotnikov

1 joint publications

Andrei I Khlebnikov